- Home
- LEGN vs ASB Comparison
LEGN vs ASB Comparison
Compare LEGN & ASB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LEGN | ASB |
|---|---|---|
| Founded | 2014 | 1861 |
| Country | United States | United States |
| Employees | N/A | 4000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 5.2B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | LEGN | ASB |
|---|---|---|
| Price | $28.48 | $28.04 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 12 |
| Target Price | ★ $61.33 | $29.75 |
| AVG Volume (30 Days) | ★ 2.3M | 1.6M |
| Earning Date | 05-12-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 3.45% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $42.68 | $21.24 |
| Revenue Next Year | $30.52 | $8.86 |
| P/E Ratio | ★ N/A | $10.23 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.24 | $22.48 |
| 52 Week High | $45.30 | $29.52 |
Technical Indicators
Market Signals| Indicator | LEGN | ASB |
|---|---|---|
| Relative Strength Index (RSI) | 60.51 | 53.55 |
| Support Level | $25.01 | $27.15 |
| Resistance Level | $29.69 | $28.86 |
| Average True Range (ATR) | 1.93 | 0.54 |
| MACD | -0.13 | -0.03 |
| Stochastic Oscillator | 71.97 | 50.51 |
Price Performance
Historical ComparisonAbout LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About ASB Associated Banc-Corp
Associated Banc-Corp is a bank holding company based in the United States of America. The company, through its subsidiaries, provides a broad array of banking and non-banking products and services to individuals and businesses. The group operates in three reportable segments: Corporate and Commercial Specialty; Community, Consumer, and Business; and Risk Management and Shared Services. The majority of its revenue is derived from the Corporate and Commercial Specialty segment, which serves a wide range of customers, including larger businesses, developers, not-for-profits, municipalities, and financial institutions by providing lending and deposit solutions as well as support to deliver, fund, and manage such banking solutions.